Date	Period	Revenue/Estimate	Earnings Call
Oct 27, 2020	2020/Q3	954.625M / 1.007B	--
Aug 26, 2020	2020/Q2	760.623M / 911.830M	--
Apr 29, 2020	2020/Q1	632.723M / 734.859M	--
--	2019/Q4	847.782M / 861.788M	--
Oct 31, 2019	2019/Q3	890.917M / 887.066M	--

DatePeriodRevenue/EstimateEarnings Call

Oct 27, 20202020/Q3954.625M / 1.007B--

Aug 26, 20202020/Q2760.623M / 911.830M--

Apr 29, 20202020/Q1632.723M / 734.859M--

--2019/Q4847.782M / 861.788M--

Oct 31, 20192019/Q3890.917M / 887.066M--

Unlock Free Earnings Estimates

Open Account

Chengdu Kanghong Pharmaceutical Group Earnings Reports

Kanghong Pharmaceutical: Report for the third quarter of 2024

Oct 24, 2024 12:00 ET

Chengdu Kanghong Pharmaceutical Group: Summary of Half-Year Report in 2024.

Aug 22, 2024 12:00 ET

Chengdu Kanghong Pharmaceutical Group: Half-year report for the year 2024.

Aug 22, 2024 12:00 ET

Kanghong Pharmaceutical: Report for the first quarter of 2024

Apr 24, 2024 12:00 ET

Top CN Stock Gainers

Symbol Price % Chg

Guangdong Hongjing Optoelectronic Technology Inc.

JiangSu Jinji Industrial

300798

9.58 +20.05%

Shandong Nanshan Fashion Sci-Tech

300918

21.34 +20.02%

See the daily top gainer.

Analysis

Analyst Rating

Updated: Mar 18, 2025

Strong Buy

Strong Buy
100.00%
Buy
0.00%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Investment Theme

Innovative Drugs

Intraday+1.62%

Monoclonal Antibody Concept

Intraday+0.97%

Biomedical

Intraday+0.73%